Editorial: The stumble toward virtual careVirtual care is here to stay but now we need to iron out the kinks. A refresher on the rare blood clot condition known as VIPIT Solve my problem: What methods does your practice use to track and encourage appropriate vaccinations? Adverse effect rates with Pfizer-BioNTech and Moderna COVID-19 vaccines Active surveillance system collects near–real-time data from mRNA COVID-19 vaccine recipients in the United States. Book review: Posner puts Pharma under the microscope A book neither pharma-sympathetic, nor anti-pharma, it still offers up big insights on the pharmaceutical industry. U.S. recommends 'pause' for J&J vaccine over clot reports My top 10 cybersecurity tips As I learned the hard way, being hacked is a matter of time—unless we take these precautions. Vaccine roll-out in the works for SK pharmacies Saskatchewan pharmacists and pharmacy technicians are expected to begin administering the Covid-19 vaccine on April 26, as the provincial government rolls out a pilot program. Virtual solutions Some provincial governments haven’t committed to continuing virtual care fee codes after the pandemic. Q and A: Maple-ing virtual solutions Maple CEO Dr. Brett Belchetz takes on criticism of his service and makes an argument for the future of virtual care fee codes. First Previous 294 295 296 297 298 Next Last
